-
-
-
-
-
-
-
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Tops Q1 EPS by 2c, provides guidance
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 7c, updates guidance
-
-
-
-
-
-
-
Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
-
-
-
-
-
-
-
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023
-
1,220,823 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

